76 results
Page 2 of 4
8-K
EX-10.1
npba7sk7fzqjy4d5
25 May 22
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
gqkb7so d4jek1282
27 Sep 21
DiaMedica Therapeutics Announces $30 Million
8:45am
8-K
EX-1.1
fivfwm0l49d5c0ixneeq
10 Aug 20
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
12:00am
8-K
EX-1.1
5hd qsh2q3es
13 Feb 20
DiaMedica Announces Pricing of Public Offering of Common Shares
4:31pm
424B5
ijqumduucn2y6fg1x73
11 Feb 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.2
2bx 8mh2bdl7u
11 Feb 20
Updated Financial Information
7:05am
424B5
p0nqcwftb v2llizodeq
11 Feb 20
Prospectus supplement for primary offering
7:02am
8-K
EX-10.1
ci7p6mon014n8g b6t
3 Jan 20
Entry into a Material Definitive Agreement
8:00am
8-K
1g7tvup701
3 Jan 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-3.2
k0q7jzcohvbnl
4 Jun 19
Entry into a Material Definitive Agreement
7:30am
DEF 14A
k298kjjni6 h6
8 Apr 19
Definitive proxy
6:04am
PRE 14A
otzbfqavty ixl0
20 Mar 19
Preliminary proxy
4:31pm
10-K
pge66h ax
19 Mar 19
Annual report
4:58pm